X T L Biopharmaceuticals reported $14.2M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 51M 46M Mar/2026
Bioline Rx USD 207M 191M Mar/2026
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
X T L Biopharmaceuticals USD 4M 6M Mar/2026